StockData
Armata Pharmaceuticals, Inc. logo

Armata Pharmaceuticals, Inc. (ARMP) stock

ARMPNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$3.17+0.51 (+19.17%)

Close on Nov 18, 2026Market cap $117.87MP/E –Yield –

Armata Pharmaceuticals operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Armata Pharmaceuticals's operating income for the twelve months ending Jun 30, 2026 was -$40.70M. For fiscal 2025 it was -$36.63M. The highest annual figure on record is -$10.23M in fiscal 2015.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$36.63M–
FY2024Dec 31, 2024-$42.44M–
FY2023Dec 31, 2023-$40.89M–
FY2022Dec 31, 2022-$36.95M–
FY2021Dec 31, 2021-$23.82M–
FY2020Dec 31, 2020-$21.59M–
FY2019Dec 31, 2019-$19.75M–
FY2018Dec 31, 2018-$17.66M–
FY2017Dec 31, 2017-$16.16M–
FY2016Dec 31, 2016-$23.38M–
FY2015Dec 31, 2015-$10.23M–
FY2014Dec 31, 2014-$14.11M–
FY2013Dec 31, 2013-$12.38M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$10.31M–
Q1 FY2026Mar 31, 2026-$8.79M–
Q4 FY2025Dec 31, 2025-$13.82M–
Q3 FY2025Sep 30, 2025-$7.78M–
Q2 FY2025Jun 30, 2025-$6.84M–
Q1 FY2025Mar 31, 2025-$8.19M–
Q4 FY2024Dec 31, 2024-$10.54M–
Q3 FY2024Sep 30, 2024-$9.76M–
Q2 FY2024Jun 30, 2024-$11.91M–
Q1 FY2024Mar 31, 2024-$10.23M–
Q4 FY2023Dec 31, 2023-$9.58M–
Q3 FY2023Sep 30, 2023-$10.34M–
Q2 FY2023Jun 30, 2023-$9.63M–
Q1 FY2023Mar 31, 2023-$11.35M–
Q4 FY2022Dec 31, 2022-$10.33M–
Q3 FY2022Sep 30, 2022-$8.62M–
Q2 FY2022Jun 30, 2022-$9.22M–
Q1 FY2022Mar 31, 2022-$8.78M–
Q4 FY2021Dec 31, 2021-$6.05M–
Q3 FY2021Sep 30, 2021-$6.14M–
Q2 FY2021Jun 30, 2021-$6.20M–
Q1 FY2021Mar 31, 2021-$5.44M–
Q4 FY2020Dec 31, 2020-$6.45M–
Q3 FY2020Sep 30, 2020-$5.62M–
Q2 FY2020Jun 30, 2020-$4.59M–
Q1 FY2020Mar 31, 2020-$4.92M–
Q4 FY2019Dec 31, 2019-$4.38M–
Q3 FY2019Sep 30, 2019-$6.78M–
Q2 FY2019Jun 30, 2019-$5.16M–
Q1 FY2019Mar 31, 2019-$3.44M–
Q4 FY2018Dec 31, 2018-$2.79M–
Q3 FY2018Sep 30, 2018-$2.43M–
Q2 FY2018Jun 30, 2018-$2.84M–
Q1 FY2018Mar 31, 2018-$3.06M–
Q4 FY2017Dec 31, 2017-$2.37M–
Q3 FY2017Sep 30, 2017-$746.00K–
Q2 FY2017Jun 30, 2017-$9.69M–
Q1 FY2017Mar 31, 2017-$3.36M–
Q4 FY2016Dec 31, 2016-$11.86M–
Q3 FY2016Sep 30, 2016-$3.41M–

More Armata Pharmaceuticals figures

See a number that looks wrong?